• Profile
Close

Bacterial population struggles can affect the potential of vaccines

Imperial College London Health News Nov 08, 2017

Scientists have shown how vaccinating against a common cause of pneumonia leads to lethal strains of bacteria being replaced by less harmful strains.

The study, published in the journal Nature Ecology & Evolution, provides a clearer picture of the complex population structures of bacteria and how different strains struggle to establish themselves.

According to the researchers, the findings could help to optimise new vaccines by predicting how they will change bacterial populations in the longer term, based on how common certain genes are among the bugs.

Streptococcus pneumoniae, or the ‘pneumococcus’, are the most common bacterial cause of pneumonia, killing hundreds of thousands of children under the age of five each year. The microbes can also cause meningitis and blood poisoning in vulnerable patients.

To combat the threat, a number of vaccines have been developed over the last decade. These interventions target the most deadly strains, enabling the body’s defences to recognise these bugs and wipe them out before they can get a foot hold and leading to a drop in childhood deaths.

In the latest study, researchers carried out a large-scale genetic analysis and modelling of pneumococcal bacteria. The findings reveal how the recently-introduced vaccines have killed off many strains from the species, enabling other less common strains to take their place.

An international team, led by Imperial College London, used three large collections of genomes, sequenced at the Wellcome Trust Sanger Institute, to follow the effects of vaccination in the UK, USA, and Netherlands.

Many strains of pneumococci were eliminated in the years following vaccination. However, follow up studies which involved taking swabs from inside children's noses – where the bacteria can live harmlessly – show that the species as a whole did not become any less common.

Analysis revealed the make-up of pneumococcal populations shifted, with the vaccine-targeted strains disappearing and less common strains – which caused less disease in children – stepping in to take their place.

The team focused on the frequency of genes throughout the populations – how common individual genes were across all strains. They found that the gene frequencies were stable in all pneumococcus populations, including before and after vaccination programmes. Computer simulations showed this was unlikely to have happened by chance, pointing to a selective force at play.

“Because a vaccine was introduced that targeted only a subset of strains, this altered the frequencies of many genes,” explained Dr Croucher, from Imperial’s School of Public Health and senior author on the paper. “But we then saw them ‘bounce back’ closer to their original frequencies.”

This stability is evidence that populations had been influenced by a particular type of selection, called negative frequency-dependent selection (NFDS), added Dr Croucher.

In this scenario, certain genes can provide an advantage when they are less common, such as after a decrease in numbers. This means those individuals which have these rarer genes are at a greater advantage, and so are more likely to survive and reproduce. The rare genes spread quickly through the population and gradually become more common.

Testing this idea was made possible by advances in computational techniques. “Our recent algorithmic breakthrough makes model estimation up to ten thousand times faster than with previous state-of-the-art methods” said Jukka Corander, a professor at Oslo and Helsinki universities and honorary faculty at the Wellcome Trust Sanger Institute, and lead author on the study.

The team believes that this model of the ebb and flow of genes helps to explain why some bacteria have such complex population structures, making them difficult to eradicate through vaccination.

They add that as this ‘genomic survei
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay